시장보고서
상품코드
1978428

병리학 분야 인공지능(AI) 시장 보고서(2026년)

Artificial Intelligence In Pathology Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

병리학 분야 인공지능(AI) 시장 규모는 최근 급성장하고 있습니다. 2025년 13억 8,000만 달러에서 2026년에는 15억 7,000만 달러에 이르고, CAGR 13.4%로 성장할 전망입니다. 지난 수년간의 성장에는 병리 워크플로우의 디지털화 진전, 정확한 암 진단에 대한 수요 증가, 제약 연구 활동의 확대, 디지털 슬라이드 스캐너 도입, 의료 영상 데이터 세트의 보급 확대 등이 주요 요인으로 꼽힙니다.

병리학 분야 인공지능(AI) 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 25억 7,000만 달러에 이르고, CAGR은 13.2%를 보일 것으로 예측됩니다. 예측 기간의 성장 요인으로는 AI 지원 진단의 활용 확대, 개인 맞춤형 의료에 대한 관심 증가, 임상 의사결정 지원에서의 AI 통합 확대, 디지털 의료 인프라에 대한 투자 증가, AI 기반 병리 진단 도구에 대한 규제 승인 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 AI 기반 디지털 병리 플랫폼 도입 확대, 종양 검출에서 딥러닝 활용 증가, 모든 슬라이드 이미징 시스템의 통합 발전, 질병 진단에서 예측 분석 확대, 병리 검사실의 워크플로우 자동화에 대한 집중도 강화 등을 꼽을 수 있습니다.

개인 맞춤형 의료에 대한 수요 증가는 향후 몇 년 동안 병리학 분야의 인공지능(AI) 시장 성장을 견인할 것으로 예측됩니다. 개인 맞춤형 의료는 각 환자의 고유한 특성, 요구, 선호도에 따라 의료 절차 및 의료 접근 방식을 조정하는 것을 의미합니다. 이러한 수요 증가는 개별 유전자 프로파일, 생활습관 요인, 특정 질병 특성에 따라 맞춤형 치료를 통해 효능을 높이고 부작용을 최소화하려는 목표에 의해 촉진되고 있습니다. 병리학 분야의 AI는 의료 영상 및 유전자 데이터를 보다 정확하고 효율적으로 분석하여 정밀한 진단, 질병 하위 유형의 더 나은 식별, 환자의 고유한 생물학적 프로파일에 맞는 맞춤형 치료 계획을 가능하게 함으로써 개인화된 의료를 지원합니다. 예를 들어, 2024년 2월 미국 맞춤형 의료 연합(PMC)이 발표한 바에 따르면, 2023년 미국 식품의약국(FDA)이 승인한 신규 맞춤형 의약품은 20개 품목으로, 신규 승인된 치료용 분자 실체의 약 38%를 차지합니다. 이는 지난 몇 년 동안에 비해 크게 증가한 수치입니다. 이처럼 개인 맞춤형 의료에 대한 수요 증가는 병리학 분야의 AI 시장 성장을 가속하고 있습니다.

병리학 분야 인공지능(AI) 시장의 주요 기업들은 진단 정확도 향상, 워크플로우 효율화, 환자 예후 개선을 위한 다조직 암 검출 도구와 같은 첨단 솔루션 개발에 주력하고 있습니다. AI를 활용한 다조직 암 검출 도구는 기반 모델과 딥러닝 알고리즘을 사용하여 디지털화된 병리 슬라이드를 분석하여 희귀 종양 및 전이 병소를 포함한 다양한 조직 유형에 걸친 검출을 가능하게 합니다. 예를 들어, 2024년 1월, 미국에 본사를 둔 디지털 병리학 기업 Paige는 자사의 기반 모델 'Virchow'를 기반으로 한 새로운 AI 용도를 발표했습니다. 이 용도는 17가지 이상의 다양한 조직 유형에 걸쳐 암을 감지할 수 있습니다. 이 솔루션은 진단 정확도 향상, 워크플로우 효율성 향상, 개인화된 환자 치료를 위한 실행 가능한 인사이트를 제공함으로써 병리과 의사들을 지원하도록 설계되었습니다.

자주 묻는 질문

  • 병리학 분야 인공지능(AI) 시장 규모는 어떻게 변화하고 있나요?
  • 병리학 분야 인공지능(AI) 시장의 성장 요인은 무엇인가요?
  • 개인 맞춤형 의료의 수요 증가는 병리학 분야 인공지능(AI) 시장에 어떤 영향을 미치고 있나요?
  • 병리학 분야 인공지능(AI) 시장의 주요 기업들은 어떤 솔루션을 개발하고 있나요?
  • 병리학 분야 인공지능(AI) 시장에서 AI를 활용한 다조직 암 검출 도구의 특징은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 시장 및 업계 지표 : 국가별

제11장 지역별/국가별 분석

제12장 아시아태평양 시장

제13장 중국 시장

제14장 인도 시장

제15장 일본 시장

제16장 호주 시장

제17장 인도네시아 시장

제18장 한국 시장

제19장 대만 시장

제20장 동남아시아 시장

제21장 서유럽 시장

제22장 영국 시장

제23장 독일 시장

제24장 프랑스 시장

제25장 이탈리아 시장

제26장 스페인 시장

제27장 동유럽 시장

제28장 러시아 시장

제29장 북미 시장

제30장 미국 시장

제31장 캐나다 시장

제32장 남미 시장

제33장 브라질 시장

제34장 중동 시장

제35장 아프리카 시장

제36장 시장 규제 상황과 투자환경

제37장 경쟁 구도와 기업 개요

제38장 기타 주요 기업 및 혁신 기업

제39장 세계 시장 경쟁 벤치마킹과 대시보드

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

LSH 26.04.09

Artificial intelligence (AI) in pathology refers to the application of machine learning algorithms and deep learning models to assist in the analysis of medical images, pattern recognition, and disease diagnosis. AI aids pathologists by automating tasks such as slide analysis, tumor detection, and grading, thereby enhancing diagnostic accuracy and efficiency. It also enables quicker processing of large datasets, which is essential for personalized medicine.

The primary components of artificial intelligence in pathology include software and scanners. Software consists of a collection of programs and algorithms specifically designed to perform tasks related to pathology, such as analyzing medical images, managing data, and supporting diagnostic and research activities. This technology employs various types of neural networks, including generative adversarial networks, convolutional neural networks, conventional neural networks, recurrent neural networks, and others. AI in pathology is utilized in drug discovery, disease diagnosis and prognosis, clinical workflows, as well as training and education. The users of these technologies encompass pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic and research institutions.

Tariffs are impacting the artificial intelligence in pathology market by increasing costs of imported digital scanners, high-resolution imaging sensors, graphic processing units, and advanced computing hardware required for AI model training and deployment. Hospitals, diagnostic laboratories, and research institutions in North America and Europe are most affected due to reliance on imported imaging and computing equipment, while Asia-Pacific faces higher costs for scanner manufacturing and export. These tariffs are raising capital investment requirements and slowing technology upgrades. However, they are also encouraging localized hardware assembly, domestic software development, and regional AI innovation ecosystems that support long-term market growth.

The artificial intelligence in pathology market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in pathology market statistics, including artificial intelligence in pathology industry global market size, regional shares, competitors with a artificial intelligence in pathology market share, detailed artificial intelligence in pathology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in pathology industry. This artificial intelligence in pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in pathology market size has grown rapidly in recent years. It will grow from $1.38 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to increasing digitization of pathology workflows, rising demand for accurate cancer diagnostics, expansion of pharmaceutical research activities, adoption of digital slide scanners, growing availability of medical imaging datasets.

The artificial intelligence in pathology market size is expected to see rapid growth in the next few years. It will grow to $2.57 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to increasing use of AI-assisted diagnostics, rising focus on personalized medicine, expansion of AI integration in clinical decision support, growing investments in digital healthcare infrastructure, increasing regulatory approvals for AI-based pathology tools. Major trends in the forecast period include increasing adoption of AI-based digital pathology platforms, rising use of deep learning for tumor detection, growing integration of whole slide imaging systems, expansion of predictive analytics in disease diagnosis, enhanced focus on workflow automation in pathology labs.

The growing demand for personalized medicine is expected to drive the growth of the artificial intelligence (AI) in pathology market in the coming years. Personalized medicine involves tailoring medical treatments and healthcare approaches to the unique characteristics, needs, and preferences of each patient. This rising demand is driven by the goal of customizing treatments based on individual genetic profiles, lifestyle factors, and specific disease characteristics, thereby enhancing efficacy and minimizing adverse effects. AI in pathology supports personalized medicine by enabling more accurate and efficient analysis of medical images and genetic data, allowing for precise diagnoses, better identification of disease subtypes, and customized treatment plans aligned with a patient's unique biological profile. For example, in February 2024, the Personalized Medicine Coalition (PMC), a U.S.-based professional membership organization, reported that in 2023, the U.S. Food and Drug Administration (FDA) approved 20 new personalized medicines, representing approximately 38 % of all newly approved therapeutic molecular entities-a significant increase compared with previous years. Thus, the increasing demand for personalized medicine is fueling the growth of the AI in pathology market.

Key players in the artificial intelligence (AI) in pathology market are focusing on developing advanced solutions, such as multi-tissue cancer detection tools, to improve diagnostic accuracy, streamline workflows, and enhance patient outcomes. AI-powered multi-tissue cancer detection tools utilize foundation models and deep-learning algorithms to analyze digitized pathology slides, enabling detection across various tissue types, including rare tumors and metastatic deposits. For example, in January 2024, Paige, a U.S.-based digital pathology company, introduced a new AI application built on its foundation model, Virchow, capable of detecting cancer across more than 17 different tissue types. This solution is designed to support pathologists by providing improved diagnostic accuracy, faster workflow efficiency, and actionable insights for personalized patient care.

In March 2023, Clarapath, a US-based medical robotics firm, acquired Crosscope for an undisclosed amount. This acquisition aims to enhance Crosscope's digital pathology platform by integrating advanced workflow tools and AI capabilities with Clarapath's automated tissue sectioning system, ultimately improving efficiency and accuracy in pathology laboratories. Crosscope is a US-based company that develops a digital pathology imaging platform that incorporates artificial intelligence to enhance analysis and diagnostics in the field of pathology.

Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.

Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence in pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence in pathology market consists of revenues earned by entities by providing services such as automated diagnostics, image analysis and interpretation, workflow optimization, and remote and telepathology. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in pathology market also includes sales of high-resolution scanners, graphics processing units (GPUs), workstations, and storage systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Pathology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence in pathology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in pathology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in pathology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Scanners
  • 2) By Neural Network: Generative Adversarial Networks; Convolutional Neural Networks; Conventional Neural Network; Recurrent Neural Networks; Other Neural Networks
  • 3) By Application: Drug Discovery; Disease Diagnosis And Prognosis; Clinical Workflow; Training And Education
  • 4) By End User: Pharmaceutical And Biotechnology Companies; Hospitals And Reference Laboratories; Academic And Research Institutes
  • Subsegments:
  • 1) By Software: Image Analysis Software; Diagnostic Workflow Software; Predictive Analytics Software
  • 2) By Scanners: Whole Slide Imaging Scanners; Digital Pathology Scanners; Multi-Spectral Imaging Scanners
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Koninklijke Philips N.V.; Hamamatsu Photonics K.K.; Leica Biosystems; Tempus Labs Inc.; Spectra AB; Lunit Inc.; Paige AI Inc.; Inspirata Inc.; Indica Labs Inc.; Flagship Biosciences Inc; Proscia Inc.; Aiforia Technologies Oy; Lumea Inc.; Optrascan Inc.; PathAI Inc.; Visiopharm A/S; Ibex Medical Analytics Ltd.; BioSymetrics Inc.; Deep Bio Inc.; Konfoong Biotech International Co Ltd.; Mindpeak GmbH; Qritive Inc.; Vuno Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence In Pathology Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Intelligence In Pathology Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence In Pathology Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Intelligence In Pathology Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of AI-Based Digital Pathology Platforms
    • 4.2.2 Rising Use Of Deep Learning For Tumor Detection
    • 4.2.3 Growing Integration Of Whole Slide Imaging Systems
    • 4.2.4 Expansion Of Predictive Analytics In Disease Diagnosis
    • 4.2.5 Enhanced Focus On Workflow Automation In Pathology Labs

5. Artificial Intelligence In Pathology Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnology Companies
  • 5.2 Hospitals
  • 5.3 Reference Laboratories
  • 5.4 Academic Institutes
  • 5.5 Medical Research Organizations

6. Artificial Intelligence In Pathology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence In Pathology Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Intelligence In Pathology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Intelligence In Pathology Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Intelligence In Pathology Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Intelligence In Pathology Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence In Pathology Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence In Pathology Market Segmentation

  • 9.1. Global Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Scanners
  • 9.2. Global Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Generative Adversarial Networks, Convolutional Neural Networks, Conventional Neural Network, Recurrent Neural Networks, Other Neural Networks
  • 9.3. Global Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education
  • 9.4. Global Artificial Intelligence In Pathology Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes
  • 9.5. Global Artificial Intelligence In Pathology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Image Analysis Software, Diagnostic Workflow Software, Predictive Analytics Software
  • 9.6. Global Artificial Intelligence In Pathology Market, Sub-Segmentation Of Scanners, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Whole Slide Imaging Scanners, Digital Pathology Scanners, Multi-Spectral Imaging Scanners

10. Artificial Intelligence In Pathology Market, Industry Metrics By Country

  • 10.1. Global Artificial Intelligence In Pathology Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global Artificial Intelligence In Pathology Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence In Pathology Market Regional And Country Analysis

  • 11.1. Global Artificial Intelligence In Pathology Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global Artificial Intelligence In Pathology Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence In Pathology Market

  • 12.1. Asia-Pacific Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence In Pathology Market

  • 13.1. China Artificial Intelligence In Pathology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence In Pathology Market

  • 14.1. India Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence In Pathology Market

  • 15.1. Japan Artificial Intelligence In Pathology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence In Pathology Market

  • 16.1. Australia Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence In Pathology Market

  • 17.1. Indonesia Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence In Pathology Market

  • 18.1. South Korea Artificial Intelligence In Pathology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence In Pathology Market

  • 19.1. Taiwan Artificial Intelligence In Pathology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence In Pathology Market

  • 20.1. South East Asia Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence In Pathology Market

  • 21.1. Western Europe Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence In Pathology Market

  • 22.1. UK Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence In Pathology Market

  • 23.1. Germany Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence In Pathology Market

  • 24.1. France Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence In Pathology Market

  • 25.1. Italy Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence In Pathology Market

  • 26.1. Spain Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence In Pathology Market

  • 27.1. Eastern Europe Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence In Pathology Market

  • 28.1. Russia Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence In Pathology Market

  • 29.1. North America Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence In Pathology Market

  • 30.1. USA Artificial Intelligence In Pathology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence In Pathology Market

  • 31.1. Canada Artificial Intelligence In Pathology Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence In Pathology Market

  • 32.1. South America Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence In Pathology Market

  • 33.1. Brazil Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence In Pathology Market

  • 34.1. Middle East Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence In Pathology Market

  • 35.1. Africa Artificial Intelligence In Pathology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa Artificial Intelligence In Pathology Market, Segmentation By Component, Segmentation By Neural Network, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence In Pathology Market Regulatory and Investment Landscape

37. Artificial Intelligence In Pathology Market Competitive Landscape And Company Profiles

  • 37.1. Artificial Intelligence In Pathology Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. Artificial Intelligence In Pathology Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. Artificial Intelligence In Pathology Market Company Profiles
    • 37.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.3. Hamamatsu Photonics K.K. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.4. Leica Biosystems Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.5. Tempus Labs Inc. Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence In Pathology Market Other Major And Innovative Companies

  • Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc.

39. Global Artificial Intelligence In Pathology Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The Artificial Intelligence In Pathology Market

41. Artificial Intelligence In Pathology Market High Potential Countries, Segments and Strategies

  • 41.1. Artificial Intelligence In Pathology Market In 2030 - Countries Offering Most New Opportunities
  • 41.2. Artificial Intelligence In Pathology Market In 2030 - Segments Offering Most New Opportunities
  • 41.3. Artificial Intelligence In Pathology Market In 2030 - Growth Strategies
    • 41.3.1. Market Trend Based Strategies
    • 41.3.2. Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제